We are live on ! Find out more
OBGC

O'Brien Greene & Co Portfolio holdings

AUM $353M
1-Year Est. Return 30.94%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+30.94%
3 Year Est. Return
+79.57%
5 Year Est. Return
+109.64%
10 Year Est. Return
AUM
$304M
AUM Growth
+$30.3M
Cap. Flow
+$4.81M
Cap. Flow %
1.58%
Top 10 Hldgs %
32.31%
Holding
145
New
12
Increased
74
Reduced
36
Closed
7

Top Buys

Rank Stock Value
1
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.3M
2
MDT icon
Medtronic
MDT
+$1.08M
3
LUMN icon
Lumen
LUMN
+$826K
4
TTE icon
TotalEnergies
TTE
+$804K
5
GLNG icon
Golar LNG
GLNG
+$765K

Sector Composition

Rank Sector Weight
1 Technology 20.08%
2 Healthcare 12.89%
3 Financials 11.05%
4 Materials 9.61%
5 Consumer Discretionary 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
76
CVS Health
CVS
$137B
$565K 0.19%
5,477
+122
+2% +$11.3K
VZ icon
77
Verizon
VZ
$197B
$562K 0.18%
10,834
+302
+3% +$15.8K
MDY icon
78
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.8B
$558K 0.18%
1,077
-45
-4% -$22.9K
LEE icon
79
Lee Enterprises
LEE
$171M
$553K 0.18%
+16,000
New +$406K
PG icon
80
Procter & Gamble
PG
$347B
$552K 0.18%
3,376
+154
+5% +$22.9K
VIG icon
81
Vanguard Dividend Appreciation ETF
VIG
$112B
$548K 0.18%
3,193
+3
+0.1% +$494
PCH
82
DELISTED
PotlatchDeltic
PCH
$533K 0.18%
8,850
+600
+7% +$33.6K
TOWN icon
83
Towne Bank
TOWN
$3.45B
$507K 0.17%
16,042
LIN icon
84
Linde
LIN
$235B
$499K 0.16%
1,440
+40
+3% +$13K
NVS icon
85
Novartis
NVS
$298B
$499K 0.16%
5,704
+130
+2% +$10.8K
DEO icon
86
Diageo
DEO
$47.5B
$491K 0.16%
2,229
+159
+8% +$32.6K
PLXP
87
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$483K 0.16%
60,340
-2,000
-3% -$23.4K
SPY icon
88
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$482K 0.16%
1,015
-59
-5% -$27.1K
BMY icon
89
Bristol-Myers Squibb
BMY
$128B
$463K 0.15%
7,426
-184
-2% -$10.8K
AMT icon
90
American Tower
AMT
$77.6B
$451K 0.15%
1,542
+92
+6% +$25.1K
MLM icon
91
Martin Marietta Materials
MLM
$34.3B
$449K 0.15%
1,020
+75
+8% +$30.4K
VB icon
92
Vanguard Small-Cap ETF
VB
$79.9B
$446K 0.15%
1,975
BTI icon
93
British American Tobacco
BTI
$131B
$440K 0.14%
11,763
+698
+6% +$24.8K
CCI icon
94
Crown Castle
CCI
$32.3B
$434K 0.14%
2,078
+32
+2% +$5.91K
MRK icon
95
Merck
MRK
$324B
$429K 0.14%
5,601
+166
+3% +$13.2K
NSC icon
96
Norfolk Southern
NSC
$76.8B
$429K 0.14%
1,442
+37
+3% +$10.3K
BG icon
97
Bunge Global
BG
$22.8B
$425K 0.14%
4,550
+250
+6% +$22.3K
NEM icon
98
Newmont
NEM
$98.6B
$409K 0.13%
6,591
+88
+1% +$4.99K
IVV icon
99
iShares Core S&P 500 ETF
IVV
$870B
$404K 0.13%
846
-100
-11% -$46.1K
SBUX icon
100
Starbucks
SBUX
$119B
$403K 0.13%
3,442
-1,318
-28% -$149K

Similar funds

O'Brien Greene & Co's Q4 2021 Portfolio in Review

As of Q4 2021, O'Brien Greene & Co held 145 positions worth $304M, up 11% from $274M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

O'Brien Greene & Co's Q4 2021 filing shows 12 new, 74 increased, 36 reduced and 7 closed positions. Its largest new stake was Golar LNG: 60,000 shares worth $743K. The largest sale was iShares Russell 2000 ETF, an estimated $1.02M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • O'Brien Greene & Co's largest Q4 2021 buy was Golar LNG: 60,000 shares worth $743K.
  • O'Brien Greene & Co added most to iShares Core S&P Small-Cap ETF in Q4 2021, an estimated $1.3M increase.
  • O'Brien Greene & Co's biggest Q4 2021 reduction was iShares Russell 2000 ETF, cutting an estimated $1.02M.
  • O'Brien Greene & Co fully exited Adecoagro in Q4 2021, selling an estimated $587K.
  • O'Brien Greene & Co's ten largest holdings make up 32% of its $304M portfolio in Q4 2021.
  • O'Brien Greene & Co opened 12 new positions and closed 7 in Q4 2021.
  • O'Brien Greene & Co's portfolio value rose 11% quarter-over-quarter to $304M.

Based on O'Brien Greene & Co's 13F filing for Q4 2021, filed 8 Feb 2022.